| Overview |
| bs-9002R-Cy5.5 |
| SAMD9 Polyclonal Antibody, Cy5.5 Conjugated |
| IF(IHC-P) |
| Human, Mouse, Rat |
| Specifications |
| Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human SAMD9 |
| 1501-1589/1589 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 54809 |
| SAM domain-containing protein 9; SAMD9; SAMD9_HUMAN; sterile alpha mot domain containing 9; Sterile alpha mot domain-containing protein 9; C7orf5. |
| Defects in SAMD9 are the cause of normophosphatemic familial tumoral calcinosis (NFTC). NFTC is an uncommon life-threatening disorder characterized by massive periarticular, and seldom visceral, deposition of calcified tumors. |
| Application Dilution |
| IF(IHC-P) |
1:50-200 |
Powered by Bioz